Article
Cross-Cohort Generalizability of Plasma Biomarker Machine Learning Models Reveals Calibration-Driven Degradation in Clinical Utility
2026-04-10
Abstract excerpt
<h4>Background</h4> Plasma biomarkers demonstrate strong within-cohort performance for identifying cerebral amyloid pathology, but their real-world clinical utility depends on generalization across populations and assay platforms. The impact of cross-cohort deployment on clinically actionable metrics such as negative predictive value (NPV) remains poorly characterized. <h4>Objective</h4> To evaluate the performa...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 85fb196a-6628-5c2c-bb67-fc57abc27a8e
- DOI
- 10.64898/2026.04.09.26350514
